AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
ON-DEMAND WEBINARS
Delve into the art of tailoring the eConsent experience to match your study and patients' specific needs, such as crafting eConsent documents, selecting appropriate delivery models, and more.
What if AI could spot risks and connect fragmented data before issues arise? Learn how agentic AI may help clinical teams shift from reactive problem-solving to proactive decisions.
In this on-demand webinar attendees will learn about the common misconceptions surrounding eConsent, as well as the benefits they can realize through a digitally-enabled approach.
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![sitees-GettyImages-1058161052]( "The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation")
The Site-Sponsor Digital Divide Is Slowing Clinical Trial InnovationClinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
-
![Komodo Health - One Day Summit 2023]( "One Day, Clinical Trials Will Represent The Real World")
One Day, Clinical Trials Will Represent The Real WorldWhat needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
![Patient with ipad]( "How eConsent Delivers Value For Sponsors")
How eConsent Delivers Value For SponsorsDelve into the data substantiating experiences with electronic informed consent to better understand their positive impact on the outcomes of clinical trials.
-
![GettyImages-1783586499 regulatory compliance]( "Regulatory Opportunities For Decentralized Clinical Trials")
Regulatory Opportunities For Decentralized Clinical TrialsProject SHASTA, a pioneering effort to measure the benefits of decentralized trial elements, reveals significant regulatory opportunities that could shape the future of clinical research.
-
![Data-security-privacy-GettyImages-1162361864]( "Beginner's Guide To 21 CFR Part 11 Compliance")
Beginner's Guide To 21 CFR Part 11 ComplianceComputer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.
-
![mobile-app-clinical-trials-GettyImages-1321691686]( "Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually Control")
Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually ControlThis piece breaks down why Agentic AI monitoring, nearly a third of trial cost, resets the economics, and why the first CRO to move first resets the price floor for everyone else.
-
![GettyImages-1169656849 eCOA]( "Tips For Better eCOA Experiences From Medable's Patient Caregiver Network")
Tips For Better eCOA Experiences From Medable's Patient Caregiver NetworkHear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.
-
![GettyImages-2195589370-clinical-development-group-tablet-table]( "Innovation And Architecture That Delivers Simplicity And Customizability")
Innovation And Architecture That Delivers Simplicity And CustomizabilityWhether you're looking for no-code simplicity, low-code adaptability, or fully programmable control, this purpose-built technology platform supports trials of all complexities with ease.
-
![video conference team meeting-GettyImages-2095813137]( "The Strategic Role Of KOLs In Rare Disease Drug Development")
The Strategic Role Of KOLs In Rare Disease Drug DevelopmentEngaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.
-
![EU-european-union-flag-map]( "EU Annex 11: How To Stay Compliant")
EU Annex 11: How To Stay CompliantEU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
